Bücher von Aamir Al Mosawi

Cerebral palsy is a heterogeneous condition associated with a non-progressive lesion, but permanent disorder of movement with limited mobility. It is generally associated with gross motor developmental delay. In moderate to severe cases motor developmental milestones such as walking may never be achieved. There are no specific therapies for cerebral palsy, and treatment of spastic cerebral palsy is generally aiming at improving mobility through muscle relaxation and physiotherapy. This is a retrospective observational study describing the treatment of spastic cerebral palsy with individualized treatment plans providing a new combination of interventions including nutritional support, muscle relaxants and the use of oral pyritinol, intramuscular piracetam, citicoline (oral and injectable), intramuscular cerebrolysin, and intramuscular nandrolone decanoate. Treatment in this study aimed primarily at improving motor development particularly standing and walking. After treatment, all the patients experienced improvement in motor development without the occurrence of any side effect.

Hereditary syndromes are generally named after the physician or a group of physicians that recognized or described them or initially provided accurate, clinical feature or the best description of the syndrome. Some genetic syndromes have been attributed unfairly and inappropriately to physicians other than those first described or recognized them. The main aim of this book is to describe the historic documentation of a rare syndrome ¿Berry-Treacher Collins syndrome¿ which has been named inappropriately by many authors, and without giving the necessary credits to the authors first recognized and described it. The occurrence of Berry-Treacher Collins syndrome in Iraq has not been reported or documented. In addition to providing the historical documentation of this syndrome, particularly the early history of its documentation during the 1940s, 1950s, and 1960s , this book describes the first case of this rare syndrome in Iraq.

Peer reviewed medical journals are established with main aim of publishing scientific reliable articles that accurately reflect current medical knowledge and add additional information to the available medical information. Medical editorship and medical editing represent some of the important tools and practices of medical knowledge management which enables doctors to generate knowledge, and to share, translate and apply what they know to create value and improve effectiveness. The aim of this book is to provide a concise but comprehensive guide about the practice of medical journals editorship and medical editing.

Lesch Nyhan syndrome is a really terrifying rare hereditary disorder that can make parents experience a horrible nightmare of several years duration. It is seems that it is wise to try to save the parents from experiencing the double nightmare of having an other child having this horrible condition, and such attempt can only be successful when the correct diagnosis can be made as early as possible. The occurrence Lesch Nyhan syndrome disease in Iraq has not been reported or documented. The aim of this book is to describe the first case of this rare syndrome in Iraq. In this case, appropriate and timely counseling could have saved parents from experiencing the suffering of having an other affected child with a horrible disorder associated with significant morbidity and little interventions to help. A second aim of this book is to describe the early documentation of Lesch Nyhan syndrome during the 1960s.

The occurrence of Charcot Marie Tooth syndrome, an incurable disorder has not been reported or documented in Iraq. In addition to providing the historical documentation of this syndrome, particularly during the early history of its documentation during the 1950s, and 1960s, this book describes the first case of familial pediatric Charcot Marie Tooth disease in Iraq. An affected Iraqi patient with this disorder was treated with a safe novel therapy for one month. The short term effect of the therapy was dramatic with noticeable improvement that has never been reported before with this condition.

Prader-Labhart-Willi syndrome was first described by John Langdon Down in 1887, but it was named after three Andrea Prader, Heinrich Willi, and Alexis Labhart who reported a group of patients with the disorder in 1956. The occurrence of Prader-Labhart-Willi syndrome in Iraq has not been reported or documented. In addition to providing the historical documentation of this syndrome, particularly the early history of its documentation during the 1950s, and 1960s, this book describes the first case of this syndrome in Iraq.

Although there are few thousands of rare diseases known to occur in humans, there is often limited professional knowledge, experience and awareness of the manifestations of them and their most appropriate management because of the small number of patients having each one of them. Diagnostic challenges and difficulties, diagnosis delay, and misdiagnoses, inappropriate or unsatisfactory management are well known to be associated with rare diseases. The aim of this book is to describe a prototype of rare disorder ¿Congenital primary cricopharyngeal achalasia, also called congenital Chevalier Jackson syndrome¿ which was observed for the first time in Iraqi patient, and its occurrence was associated with diagnostic difficulties before referral to us. The patient received management that can¿t be considered very satisfactory or very appropriate in the presence of a therapeutic intervention that is considered simple and curative for the disease.

Down syndrome (Trisomy 21) was first described by Jean-Etienne-Dominique Esquirol in 1838 and later by Edouard Séguin in 1846. However,the disorder was named after John Langdon Down, a British physician who emphasized that the syndrome is a distinct form of mental retardation in 1862. Down syndrome is the most common chromosomal disorder in humans, and its recognition is one of the basic skills needed by medical practitioners, family doctors, pediatricians, and even medical students. This book and the Atlas which is providing represent a valuable tool for mastering the recognition of this condition.

The diagnosis of rare genetically inherited metabolic disorders such as mucopolysaccharidoses is complicated by the lack of confirmatory sophisticated laboratory tests in many regions of the world such as Iraq. In the developed countries, the diagnosis of mucopolysaccharidoses relies on urine tests for excessive mucopolysaccharides and enzyme assays. However, theses tests are not available in many areas of world such as Iraq, and the diagnosis has to be made on clinical findings. Clinical diagnosis of rare disorders like mucopolysaccharidoses demands tremendous clinical skills and extensive experience because of the similarity between different types of mucopolysaccharidoses. The emergence of the new enzyme replacement therapies for some types of mucopolysaccharidoses raises the importance of the clinical diagnosis of such disorders to give the patients the chance to have the new therapy in an other country when this is possible. Maroteaux-Lamy syndrome and Hurler-Scheie syndrome have not been described or documented in Iraqi patients. The aim of this book is to describe the clinical diagnosis of these disorders in patients from Iraq.

There is no curative therapy for many of the rare genetic disorders such as Bartter syndrome. Many patients with such disorders will be treated to a large extent with symptomatic therapies, and many of them will continue to have some symptoms, and growth and mental retardation despite the traditional therapies generally known by the treating physician. The occurrence of a rare genetic disorder ¿Bartter syndrome¿ in Iraq has not been documented. In addition to providing the historical documentation of this syndrome, particularly the early history of its documentation, this book describes the occurrence of a unique case of classical pediatric Bartter syndrome associated with low set ears and mental retardation in an Iraqi patient. The patient was treated before referral by some of the traditional therapies that improved her symptoms and condition, but she experienced some side effects of treatment and growth and mental retardation. Literature review helped in recommending an evidence-based opinion suggesting the replacement of one drug with a safer one, and the addition of an other evidence-based effective therapy.

Syndromes in medicine are often named after the physician or group of physicians that discovered them or initially provided the full clinical picture or the best description of the syndrome. However, many of the rare syndromes have been described by physicians in many areas of the world before the era of the internet which has been associated with easy access to clinical reports throughout the world. Unfortunately, some syndromes have been attributed unfairly and inappropriately to physicians other that those first described them. The main aim of this book is to describe a rare syndrome ¿Mostyn Embry syndrome¿ which has not been named appropriately in any medical literature. Less than 500 cases of the classical Mostyn Embrey syndrome have been reported in the literature during the previous 100 years, and 560 cases of the classical Mostyn Embrey syndrome and its variants have reported in the literature during the previous 100 years. The second aim is to describe the first case of this rare syndrome in Iraq and the second in the ethnic Arab, and the 561 case of this syndrome in the world.

There is no satisfactory therapy for many of the disabling genetic disorders such as Semmola-Meryon-Duchenne syndrome. However, it is hoped that advances arising from the accumulating research evidence can contribute to improving treatment of such conditions. Therefore, reviewing the literature for the recent research evidence is recommended to improve the therapeutic services for patients with such disorders. The occurrence of Semmola-Meryon-Duchenne syndrome in Iraq has not been documented. In addition to providing the historical documentation of this syndrome, particularly the early history of its documentation, this book describes the occurrence of Semmola-Meryon-Duchenne syndrome in two Iraqi brothers. This book also reviews the available research evidence which may contribute to improving its treatment.